Senior officials at Massachusetts General and Brigham and Women's Hospitals are restricted to receiving no more than $5,000 a day for working on boards of pharmaceutical or biotechnology companies, reports the New York Times. Partners HealthCare forbidding employees from accepting speaker fees from drug companies. Both hospitals are Harvard teaching hospital and, the Times points out, Harvard has been looked at by Senator Charles Grassley (R-Iowa) for his examinations of conflict-of-interest in medicine. "We're the first to go in this deep, and we're still into it only up to our knees," says Eugene Braunwald, who is a Harvard professor and former Partners chief academic officer who chaired the policy-writing group.
Still Not a Bad Sum
Jan 06, 2010